Letrozole-induced reversible acute heart failure.
Serhat SekmekDogan BayramIsmet SevenPerihan PerkinOznur BalEfnan AlginPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Letrozole is one of the most commonly used HT in the treatment of hormone positive breast cancer. It may rarely cause cardiac side effects. It is very important to make patients aware of these issues and to be consulted by cardiology in case of possible cardiac symptoms.
Keyphrases
- positive breast cancer
- acute heart failure
- end stage renal disease
- left ventricular
- ejection fraction
- newly diagnosed
- polycystic ovary syndrome
- heart failure
- prognostic factors
- diabetic rats
- type diabetes
- high glucose
- patient reported outcomes
- adipose tissue
- physical activity
- endothelial cells
- insulin resistance
- sleep quality
- patient reported